Allied Market Research

2024

Biologics Safety Testing Market

Biologics Safety Testing Market Size, Share, Competitive Landscape and Trend Analysis Report by Product and Services, by Application and by Test Type : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.

Rise in pharmaceutical and biotechnology industry, huge R&D investment by key players in the life sciences industry, and increase in number of new drug launches in recent years drive the market. However, stringent government regulations for approval of biosimilars and high cost of drug development restricts the market growth. In addition, governmental support towards providing funds for biologics development and its safety is expected to provide lucrative market growth opportunities.

The global biologics safety testing market is segmented based on product & services, application, and test type. Based on test type, the market is categorized into endotoxin tests, sterility tests, cell line authentication and characterization tests, bioburden tests, cell line authentication, residual host contaminant detection tests, adventitious agent detection tests, and others. In terms of application, the market is bifurcated into vaccine development, blood products testing, cellular & gene therapy, tissue and tissue-related products testing, and stem cell research. Based on product & services, the market is categorized into kits & reagents, services, and instruments. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players of the global biologics safety testing market include Lonza Group LTD., Charles River Laboratories, Merck KGaA, SGS SA, WuXi AppTec Co., Ltd., Thermo Fisher Scientific Inc., Sartorius AG, Cytovance Biologics, Inc., Pace Analytical Services Inc., and Toxikon Corporation.

Key Benefits

  • The study provides an in-depth analysis of the global biologics safety testing market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

Biologics Safety Testing Market Report Highlights

Aspects Details
icon_5
By Product and Services
  • Kits and Reagents
  • Services
  • Instruments
icon_6
By Test Type
  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication and Characterization Tests
  • Bioburden Tests
  • Residual Host Contaminant Detection Tests
  • Adventitious Agent Detection Tests
  • Others
icon_7
By Application
  • Vaccine Development
  • Blood Products Testing
  • Cellular and Gene Therapy
  • Tissue and Tissue Related Products Testing
  • Stem Cell Research
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_9
Key Market Players

Thermo Fisher Scientific Inc., Pace Analytical Services Inc., Charles River Laboratories, Toxikon Corporation., Sartorius AG, Lonza Group LTD., SGS SA, WuXi AppTec Co., Ltd., Merck KGaA, Cytovance Biologics, Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Biologics Safety Testing Market

Global Opportunity Analysis and Industry Forecast, 2023-2032